| | | Duplication (frameshift variant) | Familial type 3 hyperlipoproteinemia +1 more | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia +1 more | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia +2 more | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy +7 more | |
| | | Single nucleotide variant (synonymous variant) | Cardiovascular phenotype +7 more | |
| | | Single nucleotide variant (splice acceptor variant) | Familial type 3 hyperlipoproteinemia | |
| | | Duplication (nonsense) | Familial hypercholesterolemia +2 more | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia +2 more | |
| | | Single nucleotide variant (synonymous variant) | Alzheimer disease 3 +8 more | |
| | | Single nucleotide variant (synonymous variant) | Lipoprotein glomerulopathy +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | Alzheimer disease 3, protection against, due to APOE3-Christchurch | |
| | | | not specified | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Alzheimer disease 3 +7 more | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia +8 more | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Hyperlipoproteinemia due to APOE1 | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Lipoprotein glomerulopathy | |
| | | Single nucleotide variant (nonsense) | Familial type 3 hyperlipoproteinemia +1 more | |
| | | Deletion (frameshift variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Duplication (inframe_insertion) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (splice acceptor variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | Cardiovascular phenotype +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial type 3 hyperlipoproteinemia | |
| | | Single nucleotide variant (missense variant) | atorvastatin response - Efficacy | |